| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Inhibrx Inc (NASDAQ: INBX)
INBX Technical Analysis
2
| As on 9th Jun 2023 INBX STOCK Price closed @ 23.39 and we RECOMMEND Buy for LONG-TERM with Stoploss of 22.37 & Strong Sell for SHORT-TERM with Stoploss of 30.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INBXSTOCK Price
| Open | 24.75 | Change | Price | % |
| High | 24.75 | 1 Day | -1.18 | -4.80 |
| Low | 23.18 | 1 Week | -0.77 | -3.19 |
| Close | 23.39 | 1 Month | 3.41 | 17.07 |
| Volume | 285939 | 1 Year | -20.74 | -47.00 |
| 52 Week High 45.06 | 52 Week Low 8.52 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| INBX Daily Charts |
INBX Intraday Charts |
Whats New @ Bazaartrend |
INBX Free Analysis |
|
|
INBX Important Levels Intraday
| RESISTANCE | 26.42 |
| RESISTANCE | 25.45 |
| RESISTANCE | 24.85 |
| RESISTANCE | 24.25 |
| SUPPORT | 22.53 |
| SUPPORT | 21.93 |
| SUPPORT | 21.33 |
| SUPPORT | 20.36 |
INBX Forecast April 2024
| 4th UP Forecast | 59.71 |
| 3rd UP Forecast | 48.06 |
| 2nd UP Forecast | 40.86 |
| 1st UP Forecast | 33.66 |
| 1st DOWN Forecast | 13.12 |
| 2nd DOWN Forecast | 5.92 |
| 3rd DOWN Forecast | -1.28 |
| 4th DOWN Forecast | -12.93 |
INBX Weekly Forecast
| 4th UP Forecast | 31.21 |
| 3rd UP Forecast | 28.70 |
| 2nd UP Forecast | 27.15 |
| 1st UP Forecast | 25.60 |
| 1st DOWN Forecast | 21.18 |
| 2nd DOWN Forecast | 19.63 |
| 3rd DOWN Forecast | 18.08 |
| 4th DOWN Forecast | 15.57 |
INBX Forecast2024
| 4th UP Forecast | 97.23 |
| 3rd UP Forecast | 73.55 |
| 2nd UP Forecast | 58.91 |
| 1st UP Forecast | 44.27 |
| 1st DOWN Forecast | 2.51 |
| 2nd DOWN Forecast | -12.13 |
| 3rd DOWN Forecast | -26.77 |
| 4th DOWN Forecast | -50.45 |
Inhibrx Inc ( NASDAQ USA Symbol : INBX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INBX Business Profile
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. Its therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 1 clinical trials in patients with solid tumors, including sarcoma; and INBRX-105, an tetravalent conditional agonist of programmed death ligand 1 (PD-L1) and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with PD-L1 expressing tumors. The company's therapeutic candidates also comprise INBRX-101, an Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with alpha-1 antitrypsin deficiency. Its preclinical programs include INBRX-106, a single domain antibody based hexavalent agonist of OX40 for a range of oncology indications. Inhibrx, Inc. was founded in 2010 and is headquartered in La Jolla, California. Address: 11025 North Torrey Pines Road, La Jolla, CA, United States, 92037
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service